Author(s): Sri Anusha Mallina, Raja Sundararajan

Email(s): mallinasrianusha@gmail.com

DOI: 10.5958/0974-360X.2018.00737.0   

Address: Sri Anusha Mallina*, Raja Sundararajan
Department of Pharmaceutical Analysis & Quality Assurance, GITAM Institute of Pharmacy,
GITAM (Deemed to be University), Visakhapatnam, Andhra Pradesh, India- 530 045
*Corresponding Author

Published In:   Volume - 11,      Issue - 9,     Year - 2018


ABSTRACT:
Multiple myeloma is an aggressive form of cancer with high mortality rates. Common treatments for multiple myeloma involve a combination of radiotherapy and chemotherapy with Lenalidomide (Lnd). A major challenge with myeloma treatment is active resistance to chemotherapeutic drugs. Superior treatment outcome lies on balance involving optimum therapeutic doses and the side effects associated with dose escalation. The aim of the present study is to efficiently entrap Lnd in lactoferrin nanoparticles (Lf NPs) in an attempt to enhance its therapeutic efficacy. Lnd loaded lactoferrin nanoparticles (Lnd-LfNPs) were prepared by sol oil method with a narrow size distribution of 120 ± 10 nm. Lnd-LfNPs exhibits high encapsulation efficiency (60 %) and increased storage stability at 4 ºC. Interestingly, Lnd-LfNPs show a pH dependent drug release similar to endosomal pH (pH 5 and 6). Furthermore, compared to free Lnd, Lnd- LfNPs showed a higher intracellular uptake, prolonged retention and improved cytotoxicity (2.7-fold) in ovarian cells (SK-OV-3). To conclude, LfNPs represent a superior nano-carrier for the targeted delivery of Lnd in cancer cells intended for the efficient treatment of melanoma though detailed in vivo investigations are warranted.


Cite this article:
Sri Anusha Mallina, Raja Sundararajan. Lenalidomide loaded lactoferrin nanoparticle for controlled delivery and enhanced therapeutic efficacy. Research J. Pharm. and Tech 2018; 11(9): 4010-4014. doi: 10.5958/0974-360X.2018.00737.0


Recomonded Articles:

Author(s): Shikha Batra, Nikhil Batra, Anil Pareek, Badri Prakash Nagori

DOI: Not Available         Access: Open Access Read More

Author(s): S. P. Wate, N. J. Duragkar, M. R. Tajne, S. S. Jadhav

DOI: Not Available         Access: Open Access Read More

Author(s): Subin Mary Zachariah, N. Aleykutty, Vidya Viswanad, Halima O.A.

DOI: Not Available         Access: Open Access Read More

Author(s): Suleiman Danladi, Mohammed Alkassim Hassan, Idris Aliyu Masa’ud, Umar Idris Ibrahim

DOI: 10.5958/0974-360X.2018.00768.0         Access: Open Access Read More

Author(s): A. Chaitanya, M. Ashok Kumar, A. Gokul Krishna, P. Shanmugasundaram.

DOI: 10.5958/0974-360X.2016.00396.6         Access: Open Access Read More

Author(s): Mahesh S Nemade, Supriya S Thorat, Rajesh Y Chaudhari, Vijay R. Patil

DOI: Not Available         Access: Open Access Read More

Author(s): Saravanan R., Dhachinamoorthi D., Renuga G., Senthilkumar K.

DOI: Not Available         Access: Open Access Read More

Author(s): Mrs. C. Maheswari*, Dr. R.Venkatnarayanan, Mr. P. Babu, Mr. C.S. Kandasamy

DOI: Not Available         Access: Closed Access Read More

Author(s): Harsha. L, Anand S

DOI: 10.5958/0974-360X.2016.00364.4         Access: Open Access Read More

Author(s): Mayur D. Doshi, Niranjan D. Chivate, Anuradha N. Chivate, Tejaswini Shingate

DOI: Not Available         Access: Open Access Read More

Author(s): Rebeccar. George, Anitha Mangesh, Dhanraj

DOI: 10.5958/0974-360X.20362817.00658.8         Access: Open Access Read More

Author(s): Manupati Prasanth, Adarsh Krishna Capoor

DOI: Not Available         Access: Open Access Read More

Author(s): Jyothi. S

DOI: 10.5958/0974-360X.2017.00729.6         Access: Open Access Read More

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags